Skip to content

Cbc Corp.

United StatesFDA applicant, unverified

Devices
5

What Cbc Corp. makes

Cbc Corp. manufactures transcutaneous electrical nerve stimulation (TENS) devices, including single-channel and dual-channel models designed for pain management. Products range from disposable single-channel units to rechargeable dual-channel systems with full functionality, catering to both clinical and home-use applications.

The company’s TENS devices are classified as Class II under FDA regulations and are authorised via 510(k) clearance. These products are listed in the FDA’s 510(k) database, adhering to US regulatory standards. The manufacturer operates from the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue5

Newest first, rows 1-5 of 5

Frequently asked questions

How many devices does Cbc Corp. have in the registry?

The registry currently lists 5 devices for Cbc Corp.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Cbc Corp.'s devices?

Among its 5 most recently registered devices, Cbc Corp. has devices listed in FDA 510(k) (5 devices).

What risk classes do Cbc Corp.'s devices fall under?

Among its 5 most recently registered devices, the classes recorded for Cbc Corp.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Cbc Corp. in the registry?

The most recently registered devices listed for Cbc Corp. include AUTO-TENS MODEL III DUAL CHANNEL REPLACE, AUTO-TENS MODEL V, AUTO-TENS MODEL IV -DUAL CHANNEL FULL and AUTO-TENS MODEL I DISPOS. SINGLE CHAN.

Generated automatically from registry data and not verified by a human reviewer.